消化道肿瘤化疗方案.pptVIP

* 在静滴方案基础上有衍生了一系列开普拓联合5Fu的持续静滴方案统称FOLFIRI方案。 * 无论是当一线或二线方案)的病人有明显延长之中位生存期 * Two international, open-label, randomised, phase III trials have compared oral Xeloda with i.v. bolus 5-FU/LV (Mayo Clinic regimen). One trial was conducted in the Americas [1] and the other was performed in Europe, the Middle East and Australasia [2]. The two trials were identical in design, selection criteria, conduct and monitoring and it was predefined to pool the data from both to obtain information on a large patient population. Therefore, a prospectively designed, integrated analysis of data from the two studies